ResMed Book Value Per Share from 2010 to 2024
RMD Stock | USD 177.61 3.78 2.17% |
Book Value Per Share | First Reported 2010-12-31 | Previous Quarter 25.33 | Current Value 26.59 | Quarterly Volatility 7.43059175 |
Check ResMed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ResMed main balance sheet or income statement drivers, such as Depreciation And Amortization of 238.6 M, Total Revenue of 5.1 B or Gross Profit of 2.8 B, as well as many exotic indicators such as Price To Sales Ratio of 4.25, Dividend Yield of 0.0183 or PTB Ratio of 4.78. ResMed financial statements analysis is a perfect complement when working with ResMed Valuation or Volatility modules.
ResMed | Book Value Per Share |
Latest ResMed's Book Value Per Share Growth Pattern
Below is the plot of the Book Value Per Share of ResMed Inc over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. ResMed's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ResMed's overall financial position and show how it may be relating to other accounts over time.
View | Last Reported 30.47 X | 10 Years Trend |
|
Book Value Per Share |
Timeline |
ResMed Book Value Per Share Regression Statistics
Arithmetic Mean | 16.08 | |
Geometric Mean | 11.21 | |
Coefficient Of Variation | 46.22 | |
Mean Deviation | 5.84 | |
Median | 14.42 | |
Standard Deviation | 7.43 | |
Sample Variance | 55.21 | |
Range | 28.0791 | |
R-Value | 0.93 | |
Mean Square Error | 7.48 | |
R-Squared | 0.87 | |
Slope | 1.55 | |
Total Sum of Squares | 772.99 |
ResMed Book Value Per Share History
Other Fundumenentals of ResMed Inc
ResMed Book Value Per Share component correlations
Click cells to compare fundamentals
About ResMed Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include ResMed income statement, its balance sheet, and the statement of cash flows. ResMed investors use historical funamental indicators, such as ResMed's Book Value Per Share, to determine how well the company is positioned to perform in the future. Although ResMed investors may use each financial statement separately, they are all related. The changes in ResMed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ResMed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ResMed Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ResMed. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Book Value Per Share | 25.33 | 26.59 | |
Tangible Book Value Per Share | 4.95 | 2.77 |
ResMed Investors Sentiment
The influence of ResMed's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ResMed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to ResMed's public news can be used to forecast risks associated with an investment in ResMed. The trend in average sentiment can be used to explain how an investor holding ResMed can time the market purely based on public headlines and social activities around ResMed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ResMed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ResMed's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ResMed's news discussions. The higher the estimated score, the more favorable is the investor's outlook on ResMed.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ResMed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ResMed's short interest history, or implied volatility extrapolated from ResMed options trading.
Currently Active Assets on Macroaxis
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out the analysis of ResMed Correlation against competitors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 1.84 | Earnings Share 6.04 | Revenue Per Share 30.633 | Quarterly Revenue Growth 0.125 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.